Overview

Effect of Omeprazole and Ritonavir on GSK2336805 Pharmacokinetics in Healthy Adults

Status:
Completed
Trial end date:
2011-11-28
Target enrollment:
Participant gender:
Summary
This study is a Phase I open label drug interaction study to evaluate the effect of omeprazole and ritonavir on GSK2336805.
Phase:
Phase 1
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Omeprazole
Ritonavir